In territories of India, Nepal, Sri Lanka and Maldives
Dr Reddys Laboratories announced that it has entered into definitive agreement to acquire a select portfolio of the established products business of UCB, in the territories of India, Nepal, Sri Lanka and Maldives. The acquired business is being sold on slump sale basis. Dr Reddys will buy select established brands of UCB in India for Rs 800 crore (Euro 118 million). The revenues for the acquired business is approximately Rs 150 crore for calendar 2014. The transaction is expected to close in the first quarter of the year 2015-16.Powered by Capital Market - Live News
